Cancer Research SA

Name

Cancer Research SA

Legal name

Cancer Research SA

Website

https://crsa.au

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Oncology Clinical Trials

NAICS

Offices of Physicians (62111), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industry

Oncology & Hematology Pharmaceuticals (HLAIAAAC)

Keywords

• Oncology clinical trials
• Cancer treatment services
• Clinical research organization
• Ethics review services
• Teletrial program access

Headquarters

HQ city

Adelaide

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical trial services: CRSA conducts clinical trials for pharmaceutical sponsors and CROs, providing efficient trial delivery with fast start-ups and ethics-only services. Trials span multiple phases (I, II, III) across various cancer types including breast, lung, bowel, prostate, ovarian and other cancers.
2. Healthcare/Patient services: Direct patient care for cancer treatment through clinical trials which are demonstrated internationally to be the gold standard choice of treatment for patients diagnosed with cancer.
3. Donations: CRSA accepts donations (non-tax deductible) with funds going towards providing improved patient care and amenities.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Cancer Research SA conducts Phase I, II and III oncology clinical trials across multiple cancer types (breast, lung, colorectal, prostate, ovarian and other solid tumours) and delivers direct cancer care and treatment to patients in South Australia. It provides an Ethics Only governance service for pharmaceutical sponsors and CROs and participates in the Australian Teletrial Program for rural and remote patients. Operations are run from a purpose-built facility alongside St Andrew's Hospital in the Adelaide CBD.

Product overview

Cancer Research SA operates as a single unified clinical research and treatment center offering Phase I, II, and III clinical trial services for various cancer types. The organization provides compassionate cancer care through a purpose-built facility in Adelaide, working alongside specialist cancer surgeons, radiation oncologists, and other medical specialties. CRSA's core offerings include treatment trials, prevention trials, screening trials, and quality of life trials, with specialized programs such as Ethics Only services for sponsors and the Australian Teletrial Program for rural patient access. The company conducts trials across multiple cancer indications including breast, lung, colorectal, prostate, ovarian, and other solid tumours.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncology Clinical Trial Services (Phase I, II & III) End-to-end Phase I, II and III oncology clinical trial conduct spanning treatment, prevention, screening and quality-of-life trials across breast, lung, bowel, prostate, ovarian and other solid tumours, delivered for pharmaceutical sponsors and CROs and accessed by patients in South Australia.
• Cancer Care and Treatment Compassionate, state-of-the-art cancer care delivered to patients in South Australia through access to novel cancer therapies and clinical trials, working alongside specialist cancer surgeons, radiation oncologists and all major medical specialties.
• Ethics Only Service Ethics committee review and governance service for pharmaceutical sponsors and CROs conducting clinical trials in Australia, offering faster approval timeframes relative to US FDA trials and supporting concept-to-commercialisation.

Quantifiable outcome

• Fast-tracked approvals and compressed timeframes for clinical trials
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature1 record

Partnerships

Six partnerships are on record, tiered core and minor.

• Australian Teletrial ProgramcoreStrategic or Co-development PartnerCRSA works closely with Australian Teletrial Program, established by the South Australian Department for Health and Wellbeing, to improve access for rural and remote patients to state-of-the-art trials.
• St Andrew's HospitalcoreStrategic or Co-development PartnerCRSA is located alongside St Andrew's Hospital in Adelaide CBD, allowing for convenient access to other specialists and healthcare options. This proximity enables collaborative cancer care delivery.
• ICON Cancer CentreminorStrategic or Co-development PartnerCRSA team members practice at various private and public hospitals including ICON Cancer Centre. Dr Sarwan Bishnoi consults at St Andrew's Hospital and is part of ICON Cancer Centre team.
• Royal Adelaide HospitalminorStrategic or Co-development PartnerCRSA oncologists practice at multiple hospitals including Royal Adelaide Hospital. Team members include Dr Chen Yong (Lyell McEwin Hospital), Dr Meena Okera (Royal Adelaide Hospital), and others who work across both private and public hospital systems.
• Local, national and international organisationsminorStrategic or Co-development PartnerCRSA partners with local, national and international organisations to provide fast, efficient trials and bring innovative cancer therapies to South Australians diagnosed with cancer.
• Lyell McEwin HospitalminorStrategic or Co-development PartnerCRSA oncologists practice at Lyell McEwin Hospital including Dr Chen Yong (Consultant Medical Oncologist), Dr Joanne Tang, Dr Nimit Singhal, and A/Prof Rohit Joshi.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ICON Cancer Centre: ICON Cancer Centre is a major Australian oncology provider where CRSA founding oncologists hold clinical appointments. Directly comparable as oncology care and clinical trial delivery, with overlapping physician networks in Adelaide.
• Linear Clinical Research: Western Australia's leading early-phase oncology clinical trials unit, conducting Phase I trials for international pharma sponsors. Comparable as specialized Australian Phase I oncology trial site leveraging TGA regulatory advantages.
• Adelaide Oncology & Haematology (AOH): Adelaide-based oncology and haematology practice explicitly named alongside CRSA as a co-member organization. Provides direct oncology care and clinical trial participation in the same South Australian geography.
• CMAX Clinical Research: Adelaide-based early-phase clinical trial unit operating from the Royal Adelaide Hospital precinct. Comparable as specialized Australian clinical trials site leveraging TGA regulatory pathway, with overlapping local physician network.
• Nucleus Network: Australia's largest early-phase clinical trial organization with Phase I units in Melbourne and Brisbane. Comparable as Australian-based clinical research site offering speed and cost advantages to international pharma sponsors.

Broad incumbents

• Peter MacCallum Cancer Centre: Australia's leading dedicated cancer hospital and research center in Melbourne, conducting extensive clinical trials. Comparable as oncology-focused clinical trial provider but operates as a large public academic institution rather than private site.
• GenesisCare: One of Australia's largest integrated oncology providers offering treatment, clinical trials, and radiation oncology across multiple states. Comparable oncology care delivery model but at significantly greater scale and geographic footprint.

Regional players

• Flinders Medical Centre Oncology: Major South Australian public hospital providing oncology care and clinical trials, where multiple CRSA founders completed oncology training. Comparable as oncology service provider in Adelaide geography though operates as public hospital.
• Royal Adelaide Hospital Cancer Centre: South Australia's largest public hospital cancer center where CRSA directors hold consultant appointments. Comparable as oncology care and clinical trial provider in same Adelaide geography, but operates as public institution.
• Scientia Clinical Research: Sydney-based early-phase clinical trial unit affiliated with UNSW and the Prince of Wales Hospital. Comparable as Australian Phase I clinical research site targeting international pharma sponsors, though operating in a different geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cancerresearchsa

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cancer Research SA